![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Bloodstream scavenger inhibits clotting without increased bleeding
A compound that mops up debris of damaged cells from the bloodstream may be...
Novartis gains FDA approval for Afinitor® in advanced breast cancerNovartis gains FDA approval for...
The US Food and Drug Administration (FDA) has approved Afinitor® (everolimus) tablets* (approval represents...
AstraZeneca to initiate a new study of BRILINTA in patients with PAD
AstraZeneca announced plans to conduct the EUCLID study, a global clinical trial involving 11,500...
GSK to acquire Human Genome Sciences for US$14.25 per share in cash
GlaxoSmithKline plc and Human Genome Sciences have entered into a definitive agreement under which...
GSK and Theravance announce regulatory submissions for FF/VI
GlaxoSmithKline plc (GSK) and Theravance, Inc. announced the submission of regulatory applications in the...
Boehringer Ingelheim pursuing health care innovationBoehringer Ingelheim pursuing health care innovation
In future patients with certain diseases, especially chronic ones, should be treated in a...
Abbott Introduces OneLab, a Novel Integrated Web-Based Software Platform to Manage the Vast Amounts...
As health care systems around the world face challenges such as labor shortages, increased...
Drug fails to curb heart bypass complications, but surgery gets safer
A drug designed to shield the heart from injury during bypass surgery failed to...
Boehringer Ingelheim establishes translational research collaboration with Harvard University
Boehringer Ingelheim has established a translational research collaboration with the Presidents and Fellows of...
Seven pharmaceutical companies join academic researchers to speed TB drug discovery
Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates...